Location: St. Helier, Jersey
CIK: 0001715579 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Jan 23, 2025
Total Value: $529M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| CNTA | CENTESSA PHARMACEUTICALS PLC | 19,963,157 | $334M | 63.2% | $16.75 | $20.88 | — | SPONSORED ADS | 152309100 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 2,869,565 | $73.75M | 13.9% | $25.70 | $10.96 | +134.6% | ORDINARY SHARES | N62509109 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 7,464,572 | $60.61M | 11.5% | $8.12 | $13.72 | -40.8% | COM | 71722W107 |
| — | RAPT THERAPEUTICS INC | 22,352,000 | $35.32M | 6.7% | $1.58 | $1.58 | — | COM | 75382E109 |
| AURA | AURA BIOSCIENCES INC | 3,039,892 | $24.99M | 4.7% | $8.22 | $17.87 | -54.0% | COM | 05153U107 |